I tried to post this on Thursday ... oh well. Research released by Amgen on Friday shows that their experimental drug (panitumamab or ABX) delayed progression of tumor growth for patients with refractory colon cancer. SInce panitumamab isn't approved, it's available only in clinical trials. For more info, see
http://www.c-three.org/news/2005/11/pan ... essi_1.php